Literature DB >> 2041437

Tolerance of the carotid-sheath contents to brachytherapy: an experimental study.

J L Werber1, B Sood, A Alfieri, S A McCormick, B Vikram.   

Abstract

Tumor invasion of the carotid artery is a potential indication for brachytherapy, which delivers a high dose of irradiation to residual tumor while limiting the dose to adjacent healthy tissues. The tolerance of carotid-sheath contents to varying doses of brachytherapy, however, has not been clearly established. In order to evaluate brachytherapy effects on carotid-sheath contents, after-loading catheters were implanted bilaterally in 3 groups of 6 rabbits each (18 rabbits). Iridium 192 brachytherapy doses of either 5000 cGy (rad), 9000 cGy, or 13,000 cGy were delivered unilaterally, with the contralateral neck serving as a nonirradiated control in each animal. There were no carotid ruptures and wound healing was normal. Two animals from each group were killed at 6, 20, and 48 weeks. Even at the highest dose (13,000 cGy), nerve conduction studies performed on the vagus nerve prior to sacrifice revealed no increased latency, histologic changes were minimal, and carotid arteries were patent. These observations suggest that the carotid-sheath contents in healthy rabbits could tolerate high doses (up to 13,000 cGy) of low-dose-rate interstitial brachytherapy without complications.

Entities:  

Mesh:

Year:  1991        PMID: 2041437     DOI: 10.1288/00005537-199106000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Aortic dose constraints when reirradiating thoracic tumors.

Authors:  Jaden D Evans; Daniel R Gomez; Arya Amini; Neal Rebueno; Pamela K Allen; Mary K Martel; Justin M Rineer; Kie Kian Ang; Sarah McAvoy; James D Cox; Ritsuko Komaki; James W Welsh
Journal:  Radiother Oncol       Date:  2013-02-28       Impact factor: 6.280

2.  Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma.

Authors:  M Bernstein; M Lumley; G Davidson; N Laperriere; P Leung
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

3.  Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.

Authors:  Tadahiko Kubo; Takashi Sugita; Shoji Shimose; Toshihiro Matsuo; Ken Hirao; Hiroaki Kimura; Masahiro Kenjo; Mitsuo Ochi
Journal:  BMC Cancer       Date:  2005-07-19       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.